Related Experiment Video
Updated: Jan 26, 2026

Studying the Role of Alveolar Macrophages in Breast Cancer Metastasis
Published on: June 26, 2016
The role of IRAK1 in breast cancer patients treated with neoadjuvant chemotherapy
Muwen Yang1, Xingsong Qin1, Guangyuan Qin2
1Department of Breast Surgery, First Affiliated Hospital, China Medical University, Shenyang, Liaoning, China, xyzheng@cmu.edu.cn.
Background:
IRAK1 has been shown to be abnormally expressed in a set of tumors leading to tumorigenesis and progression. IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel. However, the exact role of IRAK1 in neoadjuvant chemotherapy (NCT) for breast cancer remains unclear. The aim of this study was to investigate the relationship between the expression of IRAK1 and the clinicopathological parameters and survival prognosis of breast cancer patients treated with NCT.
Patients And Methods:
Based on the clinical data and mRNA microarray data from 1,085 breast cancer patients in The Cancer Genome Atlas, the correlation between IRAK1 expression and clinicopathological parameters of breast cancer was analyzed. Immunohistochemistry was performed to evaluate the expression of IRAK1. The Human Protein Atlas and the String database were used to analyze the expression of IRAK1 protein and its interaction with altered neighboring proteins in breast cancer. IRAK1 alteration was analyzed in cBioPortal database. GEO enrichment of IRAK1 was performed using WEB-based Gene SeT AnaLysis Toolkit.
Results:
The expression of IRAK1 was significantly downregulated following NCT. The decreased expression of IRAK1 following NCT was positively correlated with reduced tumor size. Finally, survival analysis confirmed that a shorter survival period was correlated to higher expression of IRAK1 both before and after NCT.
Conclusion:
These findings advanced our understanding about the expression pattern of IRAK1 in breast cancer, especially in those patients who were treated with NCT, suggesting that IRAK1 could be used as a prognostic indicator, as well as a potential indicator for evaluating NCT efficacy for breast cancer patients.
Insights
Interleukin-1 receptor-associated kinase 1 (IRAK1) expression decreases after neoadjuvant chemotherapy (NCT) in breast cancer. Lower IRAK1 levels correlate with better outcomes, suggesting IRAK1 as a prognostic marker for NCT efficacy.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Interleukin-1 receptor-associated kinase 1 (IRAK1) is implicated in tumor development and progression.
- IRAK1 is a known driver of breast cancer metastasis and paclitaxel resistance.
- The role of IRAK1 in neoadjuvant chemotherapy (NCT) for breast cancer requires further elucidation.
Purpose of the Study:
- To investigate the association between IRAK1 expression and clinicopathological features in breast cancer patients undergoing NCT.
- To evaluate IRAK1 as a potential prognostic biomarker for survival in breast cancer patients treated with NCT.
Main Methods:
- Analysis of clinical and mRNA microarray data from 1,085 breast cancer patients in The Cancer Genome Atlas.
- Immunohistochemistry to assess IRAK1 protein expression.
- Bioinformatic analysis using Human Protein Atlas, String database, cBioPortal, and GEO datasets.
Main Results:
- IRAK1 expression was significantly downregulated post-NCT.
- Decreased IRAK1 levels after NCT correlated with reduced tumor size.
- Higher IRAK1 expression, both pre- and post-NCT, was associated with shorter survival periods.
Conclusions:
- IRAK1 expression patterns in breast cancer patients treated with NCT were clarified.
- IRAK1 may serve as a valuable prognostic indicator for breast cancer patients.
- IRAK1 could potentially be used to evaluate the efficacy of NCT in breast cancer.
More Related Videos
06:06High-Throughput Dissociation and Orthotopic Implantation of Breast Cancer Patient-Derived Xenografts
Published on: December 20, 2024
15:48Tracking the Mammary Architectural Features and Detecting Breast Cancer with Magnetic Resonance Diffusion Tensor Imaging
Published on: December 15, 2014
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Role of Septins
Cellular Functions of Septins
Recent studies have revealed the multifaceted roles of septins in various cellular processes such as cytokinesis, ciliogenesis, and neurogenesis. Septins act as scaffolds and...
The Role of Culture
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Role of Hippocampus in Memory